vs

Side-by-side financial comparison of ADAMAS TRUST, INC. (ADAM) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $43.2M, roughly 1.9× ADAMAS TRUST, INC.). ADAMAS TRUST, INC. runs the higher net margin — 124.0% vs -38.1%, a 162.0% gap on every dollar of revenue. On growth, ADAMAS TRUST, INC. posted the faster year-over-year revenue change (61.6% vs 20.2%). Over the past eight quarters, ADAMAS TRUST, INC.'s revenue compounded faster (55.5% CAGR vs 24.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

ADAM vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.9× larger
PRCT
$83.1M
$43.2M
ADAM
Growing faster (revenue YoY)
ADAM
ADAM
+41.4% gap
ADAM
61.6%
20.2%
PRCT
Higher net margin
ADAM
ADAM
162.0% more per $
ADAM
124.0%
-38.1%
PRCT
Faster 2-yr revenue CAGR
ADAM
ADAM
Annualised
ADAM
55.5%
24.8%
PRCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ADAM
ADAM
PRCT
PRCT
Revenue
$43.2M
$83.1M
Net Profit
$53.5M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
124.0%
-38.1%
Revenue YoY
61.6%
20.2%
Net Profit YoY
270.5%
-27.9%
EPS (diluted)
$0.45
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADAM
ADAM
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$43.2M
$76.4M
Q3 25
$36.6M
$83.3M
Q2 25
$36.4M
$79.2M
Q1 25
$33.1M
$69.2M
Q4 24
$26.7M
$68.2M
Q3 24
$20.2M
$58.4M
Q2 24
$19.0M
$53.4M
Net Profit
ADAM
ADAM
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$53.5M
$-29.8M
Q3 25
$44.8M
$-21.4M
Q2 25
$8.5M
$-19.6M
Q1 25
$42.2M
$-24.7M
Q4 24
$-31.4M
$-18.9M
Q3 24
$42.8M
$-21.0M
Q2 24
$-15.6M
$-25.6M
Gross Margin
ADAM
ADAM
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
ADAM
ADAM
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-27.8%
Q2 25
11.7%
-28.0%
Q1 25
-39.7%
Q4 24
-119.0%
-28.9%
Q3 24
-38.4%
Q2 24
-124.7%
-50.3%
Net Margin
ADAM
ADAM
PRCT
PRCT
Q1 26
-38.1%
Q4 25
124.0%
-39.1%
Q3 25
122.5%
-25.7%
Q2 25
23.4%
-24.7%
Q1 25
127.4%
-35.8%
Q4 24
-117.5%
-27.6%
Q3 24
211.7%
-35.9%
Q2 24
-81.9%
-48.0%
EPS (diluted)
ADAM
ADAM
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.45
$-0.54
Q3 25
$0.36
$-0.38
Q2 25
$-0.04
$-0.35
Q1 25
$0.33
$-0.45
Q4 24
$-0.46
$-0.34
Q3 24
$0.36
$-0.40
Q2 24
$-0.29
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADAM
ADAM
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$210.3M
$245.6M
Total DebtLower is stronger
$735.8M
$51.7M
Stockholders' EquityBook value
$1.4B
$347.7M
Total Assets
$12.6B
$487.1M
Debt / EquityLower = less leverage
0.52×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADAM
ADAM
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$210.3M
$286.5M
Q3 25
$185.3M
$294.3M
Q2 25
$160.4M
$302.7M
Q1 25
$177.1M
$316.2M
Q4 24
$167.4M
$333.7M
Q3 24
$195.1M
$196.8M
Q2 24
$235.5M
$214.1M
Total Debt
ADAM
ADAM
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$735.8M
$51.6M
Q3 25
$766.6M
$51.6M
Q2 25
$653.0M
$51.5M
Q1 25
$654.4M
$51.5M
Q4 24
$573.2M
$51.5M
Q3 24
$699.4M
$51.4M
Q2 24
$800.7M
$51.4M
Stockholders' Equity
ADAM
ADAM
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$1.4B
$365.9M
Q3 25
$1.4B
$380.3M
Q2 25
$1.4B
$385.8M
Q1 25
$1.4B
$389.2M
Q4 24
$1.4B
$402.2M
Q3 24
$1.4B
$241.2M
Q2 24
$1.4B
$251.8M
Total Assets
ADAM
ADAM
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$12.6B
$508.1M
Q3 25
$12.4B
$511.5M
Q2 25
$10.6B
$513.1M
Q1 25
$10.0B
$519.4M
Q4 24
$9.2B
$534.0M
Q3 24
$8.9B
$374.1M
Q2 24
$8.2B
$374.4M
Debt / Equity
ADAM
ADAM
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.52×
0.14×
Q3 25
0.55×
0.14×
Q2 25
0.47×
0.13×
Q1 25
0.47×
0.13×
Q4 24
0.41×
0.13×
Q3 24
0.48×
0.21×
Q2 24
0.56×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADAM
ADAM
PRCT
PRCT
Operating Cash FlowLast quarter
$134.0M
Free Cash FlowOCF − Capex
$125.9M
FCF MarginFCF / Revenue
291.6%
Capex IntensityCapex / Revenue
18.9%
Cash ConversionOCF / Net Profit
2.50×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADAM
ADAM
PRCT
PRCT
Q1 26
Q4 25
$134.0M
$-10.3M
Q3 25
$6.9M
$-6.6M
Q2 25
$39.2M
$-15.0M
Q1 25
$25.8M
$-17.0M
Q4 24
$14.1M
$-32.4M
Q3 24
$-922.0K
$-18.8M
Q2 24
$-993.0K
$-15.7M
Free Cash Flow
ADAM
ADAM
PRCT
PRCT
Q1 26
Q4 25
$125.9M
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-10.6M
$-33.6M
Q3 24
$-8.6M
$-19.0M
Q2 24
$-8.6M
$-16.8M
FCF Margin
ADAM
ADAM
PRCT
PRCT
Q1 26
Q4 25
291.6%
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-39.6%
-49.2%
Q3 24
-42.3%
-32.6%
Q2 24
-44.9%
-31.4%
Capex Intensity
ADAM
ADAM
PRCT
PRCT
Q1 26
Q4 25
18.9%
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
92.3%
1.7%
Q3 24
37.7%
0.4%
Q2 24
39.7%
2.0%
Cash Conversion
ADAM
ADAM
PRCT
PRCT
Q1 26
Q4 25
2.50×
Q3 25
0.15×
Q2 25
4.59×
Q1 25
0.61×
Q4 24
Q3 24
-0.02×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADAM
ADAM

Other$19.6M45%
Constructive Loans LLC$14.4M33%
Multifamily$9.1M21%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons